ELOX logo

Eloxx Pharmaceuticals (ELOX) Operating Expenses

Annual Operating Expenses

$34.42 M
-$31.60 M-47.86%

December 31, 2022


Summary


Performance

ELOX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXexpensesmetrics:

Quarterly Operating Expenses

$3.64 M
-$503.00 K-12.15%

September 30, 2023


Summary


Performance

ELOX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

ELOX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-47.9%-49.1%
3 y3 years-31.9%-42.2%
5 y5 years+80.2%-74.2%

ELOX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.9%at low-68.7%at low
5 y5-year-47.9%+16.9%-89.8%at low
alltimeall time-47.9%-100.0%-89.8%+963.8%

Eloxx Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Sep 2023
-
$3.64 M(-12.1%)
Jun 2023
-
$4.14 M(-24.5%)
Mar 2023
-
$5.48 M(-9.0%)
Dec 2022
$34.42 M(-47.9%)
$6.03 M(-15.6%)
Sep 2022
-
$7.14 M(-30.6%)
Jun 2022
-
$10.30 M(-6.0%)
Mar 2022
-
$10.95 M(-5.8%)
Dec 2021
$66.02 M(+124.3%)
$11.63 M(+13.5%)
Sep 2021
-
$10.24 M(-71.3%)
Jun 2021
-
$35.73 M(+324.6%)
Mar 2021
-
$8.41 M(+45.5%)
Dec 2020
$29.44 M(-41.8%)
$5.78 M(-8.2%)
Sep 2020
-
$6.30 M(-17.0%)
Jun 2020
-
$7.59 M(-22.4%)
Mar 2020
-
$9.77 M(-14.9%)
Dec 2019
$50.55 M(+7.6%)
$11.49 M(-10.1%)
Sep 2019
-
$12.78 M(-10.7%)
Jun 2019
-
$14.31 M(+19.5%)
Mar 2019
-
$11.98 M(-15.1%)
Dec 2018
$46.97 M(+145.9%)
$14.11 M(+24.2%)
Sep 2018
-
$11.36 M(-17.1%)
Jun 2018
-
$13.71 M(+111.2%)
Mar 2018
-
$6.49 M(+934.6%)
Dec 2017
$19.10 M(+791.4%)
-
Sep 2017
-
$627.60 K(+17.7%)
Jun 2017
-
$533.00 K(+55.9%)
Jun 2017
$2.14 M(-43.5%)
-
Mar 2017
-
$341.90 K(-32.6%)
Dec 2016
-
$507.50 K(-33.2%)
Sep 2016
-
$760.20 K(+9.1%)
Jun 2016
$3.79 M(-51.0%)
$696.50 K(-23.3%)
Mar 2016
-
$908.10 K(-8.8%)
Dec 2015
-
$995.60 K(-16.3%)
Sep 2015
-
$1.19 M(+24.3%)
Jun 2015
$7.74 M(+10.2%)
$956.50 K(-24.2%)
Mar 2015
-
$1.26 M(-51.9%)
Dec 2014
-
$2.63 M(-9.3%)
Sep 2014
-
$2.89 M(+76.9%)
Jun 2014
$7.02 M(+53.1%)
$1.64 M(-23.1%)
Mar 2014
-
$2.13 M(+34.0%)
Dec 2013
-
$1.59 M(-4.7%)
Sep 2013
-
$1.67 M(+67.5%)
Jun 2013
$4.59 M(-13.3%)
$995.80 K(-4.6%)
Mar 2013
-
$1.04 M(-19.7%)
Dec 2012
-
$1.30 M(+4.3%)
Sep 2012
-
$1.25 M(+0.1%)
Jun 2012
$5.29 M(-13.1%)
$1.25 M(+12.3%)
Mar 2012
-
$1.11 M(-33.1%)
Dec 2011
-
$1.66 M(+29.4%)
Sep 2011
-
$1.28 M(+27.0%)
DateAnnualQuarterly
Jun 2011
$6.09 M(+22.1%)
$1.01 M(-26.3%)
Mar 2011
-
$1.37 M(-9.1%)
Dec 2010
-
$1.50 M(-31.8%)
Sep 2010
-
$2.21 M(+27.6%)
Jun 2010
$4.99 M(+9.4%)
$1.73 M(+54.2%)
Mar 2010
-
$1.12 M(-2.7%)
Dec 2009
-
$1.15 M(+17.2%)
Sep 2009
-
$983.70 K(-19.7%)
Jun 2009
$4.56 M(+12.4%)
$1.22 M(+14.1%)
Mar 2009
-
$1.07 M(-12.7%)
Dec 2008
-
$1.23 M(+18.8%)
Sep 2008
-
$1.03 M(+5.1%)
Jun 2008
$4.06 M(+12.0%)
$984.50 K(-27.1%)
Mar 2008
-
$1.35 M(+38.1%)
Dec 2007
-
$978.10 K(+31.8%)
Sep 2007
-
$742.00 K(-2.0%)
Jun 2007
$3.62 M(+3.9%)
$756.90 K(-8.6%)
Mar 2007
-
$828.50 K(-38.3%)
Dec 2006
-
$1.34 M(+93.9%)
Sep 2006
-
$692.60 K(-14.7%)
Jun 2006
$3.49 M(+1.1%)
$812.40 K(+4.5%)
Mar 2006
-
$777.40 K(-18.5%)
Dec 2005
-
$954.20 K(+1.3%)
Sep 2005
-
$942.00 K(+8.0%)
Jun 2005
$3.45 M(-15.0%)
$872.50 K(-6.6%)
Mar 2005
-
$934.50 K(+4.3%)
Dec 2004
-
$895.70 K(+20.4%)
Sep 2004
-
$744.00 K(-48.1%)
Jun 2004
$4.05 M(+77.9%)
$1.43 M(+133.3%)
Mar 2004
-
$614.70 K(-31.6%)
Dec 2003
-
$898.70 K(-36.3%)
Sep 2003
-
$1.41 M(+189.7%)
Jun 2003
$2.28 M(-1.5%)
$487.20 K(-8.4%)
Mar 2003
-
$532.10 K(-25.3%)
Dec 2002
-
$712.10 K(+30.1%)
Sep 2002
-
$547.20 K(+23.1%)
Jun 2002
$2.31 M(+17.4%)
$444.60 K(-10.3%)
Mar 2002
-
$495.50 K(-43.5%)
Dec 2001
-
$876.40 K(+76.1%)
Sep 2001
-
$497.70 K(+25.1%)
Jun 2001
$1.97 M(-19.5%)
$397.80 K(-13.7%)
Mar 2001
-
$461.00 K(-21.2%)
Dec 2000
-
$585.30 K(+11.0%)
Sep 2000
-
$527.10 K(-13.9%)
Jun 2000
$2.45 M(+111.7%)
$611.90 K(-26.0%)
Mar 2000
-
$827.40 K(+65.5%)
Dec 1999
-
$500.00 K
Jun 1999
$1.16 M(>+9900.0%)
-
Jun 1998
$0.00(0.0%)
-
Jun 1997
$0.00
-

FAQ

  • What is Eloxx Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual operating expenses year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly operating expenses year-on-year change?

What is Eloxx Pharmaceuticals annual total operating expenses?

The current annual operating expenses of ELOX is $34.42 M

What is the all time high annual operating expenses for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual total operating expenses is $66.02 M

What is Eloxx Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, ELOX annual total operating expenses has changed by -$31.60 M (-47.86%)

What is Eloxx Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of ELOX is $3.64 M

What is the all time high quarterly operating expenses for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly total operating expenses is $35.73 M

What is Eloxx Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, ELOX quarterly total operating expenses has changed by -$3.50 M (-49.08%)